MEDTRONIC EUROPE SARL – Trademark Portfolio
Entity Type: 16
MEDTRONIC EUROPE SARL holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 17 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 20 trademarks are registered. Notable registered marks include EXACT, XPEDE, KYPHON, ACTIVOS, and KYPHON V. The owner is based in TOLOCHENAZ.
ROUTE DU MOLLIAU 31
TOLOCHENAZ CH-1131 , CH
Showing of trademarks Trademarks
Trademark Classifications
MEDTRONIC EUROPE SARL's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does MEDTRONIC EUROPE SARL have?
MEDTRONIC EUROPE SARL has 21 U.S. trademarks filed with the USPTO. Of these, 20 registered, 1 cancelled.
What trademark classes does MEDTRONIC EUROPE SARL file in?
MEDTRONIC EUROPE SARL files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are MEDTRONIC EUROPE SARL's most well-known trademarks?
MEDTRONIC EUROPE SARL's registered trademark portfolio includes well-known marks such as EXACT, XPEDE, KYPHON, ACTIVOS, and KYPHON V. These are among 20 currently registered trademarks in the portfolio.
What is MEDTRONIC EUROPE SARL's trademark registration success rate?
MEDTRONIC EUROPE SARL has a 95% trademark registration rate, with 20 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.